| Ticker Details |
Alphatec Holdings, Inc.
Alphatec Holdings Inc is a medical technology company. It is engaged in the design, development and promotion of products for the surgical treatment of spine disorders. Its product portfolio includes Biolocs, cervical, interbody, and others.
|
| IPO Date: |
June 2, 2006 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$1.27B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.16 | 3.03%
|
| Avg Daily Range (30 D): |
$0.35 | 3.72%
|
| Avg Daily Range (90 D): |
$0.34 | 2.88%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.51M |
| Avg Daily Volume (30 D): |
3.61M |
| Avg Daily Volume (90 D): |
2.82M |
| Trade Size |
| Avg Trade Size (Sh.): |
115 |
| Avg Trade Size (Sh.) (30 D): |
106 |
| Avg Trade Size (Sh.) (90 D): |
90 |
| Institutional Trades |
| Total Institutional Trades: |
2,932 |
| Avg Institutional Trade: |
$1.92M |
| Avg Institutional Trade (30 D): |
$1.82M |
| Avg Institutional Trade (90 D): |
$2.47M |
| Avg Institutional Trade Volume: |
.15M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.3M |
| Avg Closing Trade (30 D): |
$3.35M |
| Avg Closing Trade (90 D): |
$4.43M |
| Avg Closing Volume: |
183.84K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q3 2025 |
|
Basic EPS
|
|
$-.22
|
$-.19
|
|
Diluted EPS
|
|
$-.22
|
$-.19
|
|
Revenue
|
|
$192.11M
|
$196.5M
|
|
Gross Profit
|
|
$136.48M
|
$137.3M
|
|
Net Income / Loss
|
|
$-33.91M
|
$-28.58M
|
|
Operating Income / Loss
|
|
$-22.58M
|
$-15.93M
|
|
Cost of Revenue
|
|
$55.63M
|
$59.2M
|
|
Net Cash Flow
|
|
$-20.38M
|
$-1.16M
|
|
PE Ratio
|
|
|
|
|
|
|
